Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|January 2, 2023
Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responsesAlba Llibre, Nikaïa Smith, Vincent Rouilly, et al.
Thorax|November 1, 2019
Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhageMarie-Louise Frémond, Marie Legendre, Michael Fayon, et al.
The Journal of Experimental Medicine|April 14, 2025
Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblainsFanny Saidoune, Danyel Lee, Jeremy Di Domizio, et al.
Rheumatology (Oxford, England)|May 24, 2025
Myositis-specific autoantibody subtypes are associated with response to Janus kinase inhibitors in patients with juvenile dermatomyositisBrigitte Bader-Meunier, Thomas R J Moreau, Florence Aeschlimann, et al.
Journal of Autoimmunity|October 10, 2019
Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centersClaire Mj Lefeuvre, Cloé A Payet, Odessa-Maud Fayet, et al.
Nature Immunology|September 2, 2021
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infectionNikaïa Smith, Pedro Goncalves, Bruno Charbit, et al.
Brain : a Journal of Neurology|May 10, 2018
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositisLeandro Ladislau, Xavier Suárez-Calvet, Ségolène Toquet, et al.
Cell Reports|June 29, 2022
Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activationCeline Posseme, Alba Llibre, Bruno Charbit, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 27, 2026
An unusual case of RIPK1-related immunodeficiency: The importance of a timely diagnosis for a novel clinical and therapeutic patternAnne-Sophie Parentelli, Anne-Aurélie Lopes, Paul Bastard, et al.
Science Advances|July 17, 2019
Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatmentNikaïa Smith, Mathieu P Rodero, Nassima Bekaddour, et al.
Pageof 8